Peptide Schedule
KLOW Blend (BPC-157 + TB-500 + GHK-Cu + KPV)22 residues (approx.)GEPPPGKPADDAGLVLKKTETQEach bubble = one amino acid. Size = residue mass. Color = chemical class.Uses closest standard amino acids for non-standard residues.KLOW Blend (BPC-157 + TB-500 + GHK-Cu + KPV) Dosage Calculator
The KLOW Protocol is a pre-blended four-peptide stack that combines GHK-Cu, BPC-157, TB-500, and KPV into a single 80mg vial.
2mg · Daily
Summary: Add 3mL BAC water to your 80mg vial. Draw to 7.5 units on a U-100 syringe for a 2mg dose. This vial will last 40 doses.
Cycle Planner
KLOW Blend (BPC-157 + TB-500 + GHK-Cu + KPV) Pharmacokinetics
KLOW Blend (BPC-157 + TB-500 + GHK-Cu + KPV) Dosing Protocol
| Level | Dose / Injection | Frequency |
|---|---|---|
| Beginner | 2mg | Daily |
| Moderate | 4mg | Daily |
| Aggressive | 6mg | Daily |
Note: Four-peptide recovery and body recomposition stack in a fixed 80mg vial: GHK-Cu (50mg) + BPC-157 (10mg) + TB-500 (10mg) + KPV (10mg). Doses shown are the combined total in mcg per injection. Start at the beginner tier for 2 weeks before increasing. Reconstitute with 3mL bacteriostatic water for a concentration of ~26.7mg/mL. Rotate injection sites between the abdomen and outer thigh. Many users pair KLOW with a GLP-1 agonist for weight loss — the KLOW blend helps preserve tissue integrity, reduce inflammation, and support gut healing during caloric restriction. Pin once daily, preferably in the evening.
About KLOW Blend (BPC-157 + TB-500 + GHK-Cu + KPV)
The KLOW Protocol is a pre-blended four-peptide stack that combines GHK-Cu, BPC-157, TB-500, and KPV into a single 80mg vial. Originally developed as a recovery and tissue repair blend, it's gained traction in the weight management space because of its ability to support body recomposition during aggressive fat loss phases. Each component targets a different biological pathway. GHK-Cu (50mg per vial) is a copper-binding tripeptide first isolated by Loren Pickart in 1973. It drives collagen and elastin synthesis, supports skin tightening during weight loss, and activates antioxidant gene expression. BPC-157 (10mg per vial) is a 15-amino-acid fragment derived from human gastric juice. Predrag Sikiric's research group in Zagreb has published over 100 preclinical studies showing it accelerates tendon, ligament, and gut mucosal healing — all of which matter during caloric restriction when tissue repair slows. TB-500 (10mg per vial) is a synthetic fragment of thymosin beta-4. Goldstein and Kleinman's early work demonstrated its role in cell migration, angiogenesis, and wound repair. It helps maintain muscle integrity during aggressive cutting phases. KPV (10mg per vial) is a C-terminal tripeptide from alpha-melanocyte stimulating hormone. Bhatt et al. (2008) showed it enters intestinal epithelial cells via the PepT1 transporter and suppresses NF-kB inflammatory signaling at nanomolar concentrations. This makes KPV especially useful for calming gut inflammation triggered by dietary changes or GLP-1 agonist side effects. The blend doesn't directly burn fat. Instead, it creates a protective internal environment — healing the gut lining, reducing systemic inflammation, preserving connective tissue, and supporting skin elasticity — that allows users to sustain more aggressive weight loss protocols with fewer side effects and less tissue breakdown.